Course Description (for QB) Rare diseases affect 10% of the U.S. population but account for more than $1.2 trillion in annual healthcare costs (NIH NACTS, 2023). This is about one-fourth to one-third of overall U.S. healthcare costs (Tisdale, 2021). The systemic impact of rare diseases has robust burdens, affecting patients and families, healthcare systems, employment workforces, and socioeconomic and government sectors. One is not mutually likely to be medically gaslit when providers are trying to diagnose invisible complex and rare autoimmune conditions exclusive of the other. However, the true systemic impact of rare diseases is not fully known. Thus, this renders rare diseases largely invisible to those who do not suffer from them and to the overall systems impacted by them.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Bahamas Medical Council (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.00 contact hours for participating in this course.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Florida Board of Nursing (CEBroker Provider #50-290)
Florida Board of Osteopathic Medicine (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Florida Physician Assistants (CEBroker Provider #50-290)
Georgia Board of Nursing (CEBroker Provider #50-290)
Georgia Composite Medical Board - Physician Assistants (CEBroker Provider #50-290)
Kansas State Board of Nursing (CEBroker Provider #50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Louisiana State Board Of Medical Examiners - Midwifery (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Michigan Board of Nursing (CEBroker Provider #50-290)
Michigan Board of Osteopathic Medicine and Surgery (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Mississippi Board of Nursing (CEBroker Provider #50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
New Hampshire Medical Society (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
New Mexico Board of Nursing (CEBroker Provider #50-290)
New Mexico Certified Nurse Midwives and Licensed Midwives (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
North Dakota Board of Nursing (CEBroker Provider #50-290)
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Oklahoma Board Of Medical Licensure And Supervision - Medical Doctors (CEBroker Provider #50-290) Physicians will receive 1.00 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)>
Physicians will receive 1.00 AMA PRA category 1 Credits™
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Wyoming Board of Nursing (CEBroker Provider #50-290)
Outline:
Overview
Introducing the Zebra
Key Takeaways
Patient Impact
Ariana
The Diagnostic Odyssey
The Never-Ending Story
Invisible
Systems Impact
Intersecting System Burdens
Key Takeaways
Strategies for Unmet Needs
Fixing a Broken Healthcare System
Concept Connection
Key Takeaways
Conclusion
Course Summary
Course Contributor
Resources
References
Shalla is a subject matter expert (SME)/writer for Relias. She completed her BSN and two undergraduate degrees with top honors from the University of Wisconsin-Madison. Shalla earned her dual MSN degrees from Johns Hopkins University with top honors. She also maintains her post-baccalaureate nurse educator certificate (NE-BC). Shalla’s tenure spans over 20 years of cross-functional leadership and direct clinical roles in healthcare, biopharma/biotech, government affairs, managed care/market access, nonprofit patient advocacy, and research. Her subject matter expertise is in rare, orphan, and complex diseases. Her sub-expertise is in immune-mediated diseases (rheumatology and immunology), genetics, neurology, hematology/oncology, several pediatric diseases, population/public health, and larger systemic healthcare affairs. Shalla is a published author with leading rare disease experts and a global speaker. She also sits on scientific, advocacy, and legislative advisory boards. She has led national advocacy and disease awareness campaigns, including speaking before congress, leading to the first-in-class rare disease biologic approval and investigative treatment protocols.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.